For comments, suggestions
Created with Raphaël 2.1.0 27.04.2016 Filing date 25.06.2019 Validation fee payment 30.09.2019 (A1) Patent application published 25.02.2021 AGEPI application filing date 30.06.2021 (T2) Translation of the validated European patent 27.04.2022 Valid until 28.02.2023 (MM4E) Forfeiture of rights 30.11.2023 (MM4E) Forfeiture of rights

Patent lapsed


(210)Number of the EPO application18189193
(220)Filing date of the EPO application2016.04.27
(80)EPO patent specification publication (B)EPB nr. 01/2021, 2021.01.06
(110)EPO patent number3428170
(11)Number of the documentMD 3428170 T2
(21)Number of the applicatione 2019 0845
(71)Name(s) of applicant(s), code of the countrySHIONOGI & CO., LTD, JP;
(72)Name(s) of inventor(s), code of the countryKAWAI Makoto, JP;
TOMITA Kenji, JP;
AKIYAMA Toshiyuki, JP;
OKANO Azusa, JP;
MIYAGAWA Masayoshi, JP;
(73)Name(s) of owner(s), code of the countrySHIONOGI & CO. LTD, JP;
(54)Title of the inventionAnti-influenza polycyclic pyridone derivative and prodrug thereof
(13)Kind-of-document code T2
(51)International Patent Classification C07D 498/14 (2006.01.01); A61P 31/16 (2006.01.01); A61K 31/5383 (2006.01.01)
(19)CountryJP
(41)Date of publication of the application2019.09.30
(49)Date of publication of the translation of the validated European patent specification2021.06.30
(30)Priority2015090909, 2015.04.28, JP; 2015236844, 2015.12.03, JP
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
Up
/Inventions/details/3428170